Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Janež, Andrej
SAMAS, NCT05147896: Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients	Recruiting	N/A	100	Europe	Semaglutide Oral Tablet, Rybelsus	University Medical Centre Ljubljana, University of Palermo	Diabetes Mellitus, Type 2, Atherosclerosis	05/23	12/23
Janic, Miodrag
SAMAS, NCT05147896: Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients	Recruiting	N/A	100	Europe	Semaglutide Oral Tablet, Rybelsus	University Medical Centre Ljubljana, University of Palermo	Diabetes Mellitus, Type 2, Atherosclerosis	05/23	12/23